CXCR3 and neoplasm: M1-like macrophages penetrate the TME during the early phase of tumor by antigen presentation and secreting CXCL9, CXCL10, and CXCL11, which chemoattract CXCR3-expressing effector immune cells like CD8+ cytotoxic T cells and NK cells (9, 59).